Inspection Record

Patheon Softgels Inc. — Health Canada Inspection Findings

Health CanadaInspected 2024-03-04 13 findingsComplaint and recall handlingEquipment and facilityStability and storageOther quality systemCleaning validationRegulatory reporting and change controlDeviation, CAPA, and investigationLaboratory and QC controlsComputer system validation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Complaint and recall handling

The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.

2Equipment and facility

The premises were not designed, constructed, and/or maintained to prevent the entry of pests and/or foreign material into the building.

3Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

4Equipment and facility

The maintenance of records was inadequate.

5Other quality system

The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate.

6Cleaning validation

The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions.

7Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

8Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

9Other quality system

The recorded information or details were inadequate.

10Laboratory and QC controls

The receipt, preparation, and/or handling of reagents and culture media was inadequate. The creation, maintenance, processing, and/or review of laboratory data was inadequate.

11Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate. The preventative maintenance program was inadequate for the equipment used in significant processing and/or testing operations.

12Other quality system

The implementation of a self-inspection program was inadequate.

13Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2024-03-04. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Patheon Softgels Inc. company profile — full history Health Canada documents, 2024 Go to Findings search